Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates

Cerus (CERS) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of$ 0.05. This compares to loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this biomedical products company would post a loss of$ 0.01 per share when it actually produced a loss of $0.01, delivering no surprise.Over the last four quarters, the company has surpassed ...